Cargando…
Changes in tear volume and ocular symptoms of patients receiving oral anticancer drug S-1
BACKGROUND: Most eye disorders are not fatal but may deteriorate the quality of life of a patient. The eye disorder that is most frequently reported in the cancer chemotherapy is associated with the combination of tegafur/gimeracil/potassium oxonate (S-1). However, preventive methods or treatment me...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803866/ https://www.ncbi.nlm.nih.gov/pubmed/29445512 http://dx.doi.org/10.1186/s40780-018-0100-8 |